RNA editing in kinetoplastid mitochondria occurs by a series of enzymatic steps that is catalyzed by a macromolecular complex. Four novel proteins and their corresponding genes were identified by mass spectrometric analysis of purified editing complexes from Trypanosoma brucei. These four proteins, TbMP81, TbMP63, TbMP42, and TbMP18, contain conserved sequences to various degrees. All four proteins have sequence similarity in the C terminus; TbMP18 has considerable sequence similarity to the C-terminal region of TbMP42, and TbMP81, TbMP63, and TbMP42 contain zinc finger motif(s). Monoclonal antibodies that are specific for TbMP63 and TbMP42 immunoprecipitate in vitro RNA editing activities. The proteins are present in the immunoprecipitates and sediment at 20S along with the in vitro editing, and RNA editing ligases TbMP52 and TbMP48. Recombinant TbMP63 and TbMP52 coimmunoprecipitate. These results indicate that these four proteins are components of the RNA editing complex and that TbMP63 and TbMP52 can interact.RNA editing in trypanosomes posttranscriptionally inserts and deletes uridylates (U's) at multiple sites in most mitochondrial pre-mRNAs to produce mature mRNAs. U insertion and deletion are directed by guide RNAs (gRNAs) and are catalyzed by a macromolecular complex. Editing occurs by a series of enzymatic steps that include endoribonuclease, 3Ј terminal uridylyl transferase (TUTase), 3Ј exouridylylase, and RNA ligase activities (reviewed in references 3, 8, 21, and 23). Although editing can be extensive, with the insertion and deletion of numerous U's, it is also very specific. The characteristics of the enzymatic activities contribute to this specificity (7), but noncatalytic proteins may be required for editing and may contribute to the specificity.RNA editing is catalyzed by a 20S ribonucleoprotein complex (2, 15), and identification of its components and the composition of the fully functional complex is at an early stage. Initial studies estimated that a complex that can catalyze at least some of the steps of editing in vitro contains 7 to 20 polypeptides (11,14,16). Two related proteins, TbMP52 and TbMP48, were identified by mass spectrometric analysis of purified editing complexes (14), and TbMP52 was shown to be essential for RNA editing and for survival of bloodstream forms in vivo and in vitro (19). In addition, TbMP52 and TbMP48 correspond to the larger and smaller adenylatable proteins in the RNA editing complex, respectively, and were found to be RNA ligases (12,17,19). TbMP52 corresponds to T. brucei V and T. brucei p52 and TbMP48 corresponds to T. brucei IV and T. brucei p48 (12,17). The fully functional editing complex, which may consist of a catalytic core complex and accessory and regulatory factors may contain numerous proteins. Several other candidate proteins, some of which have RNA binding activities, have been described and may play a role in RNA editing (6, 9, 11, 13, 25). However, except for mHel61p (13), none of these proteins have been shown to play a direct role in editing.I...
RNA editing in kinetoplastid mitochondria inserts and deletes uridylates at multiple sites in pre-mRNAs as directed by guide RNAs. This occurs by a series of steps that are catalyzed by endoribonuclease, 3-terminal uridylyl transferase, 3-exouridylylase, and RNA ligase activities. A multiprotein complex that contains these activities and catalyzes deletion editing in vitro was enriched from Trypanosoma brucei mitochondria by sequential ion-exchange and gel filtration chromatography, followed by glycerol gradient sedimentation. The complex size is approximately 1,600 kDa, and the purified fraction contains 20 major polypeptides. A monoclonal antibody that was generated against the enriched complex reacts with an ϳ49-kDa protein and specifically immunoprecipitates in vitro deletion RNA editing activity. The protein recognized by the antibody was identified by mass spectrometry, and the corresponding gene, designated TbMP52, was cloned. Recombinant TbMP52 reacts with the monoclonal antibody. Another novel protein, TbMP48, which is similar to TbMP52, and its gene were also identified in the enriched complex. These results suggest that TbMP52 and TbMP48 are components of the RNA editing complex.Several mitochondrial RNAs are posttranscriptionally edited in kinetoplastid protozoa by the insertion and deletion of uridylates (U's) at multiple sites, to produce mature mRNAs. RNA editing creates initiation and termination codons and the likely functional open reading frames (ORFs). Indeed, translation of edited RNA has recently been directly demonstrated (11). The RNA editing appears to regulate mitochondrial respiration in different life cycle stages of Trypanosoma brucei. The insertion and deletion of U's is directed by small RNAs that are called guide RNAs (gRNAs). The editing occurs by a series of enzymatic steps. These steps include gRNA-directed cleavage of the pre-mRNA by endoribonuclease, U addition or removal at the 3Ј end of the 5Ј cleavage product by 3Ј-terminal uridylyl transferase (TUTase) or 3Ј-exouridylylase, respectively, and ligation of 5Ј and 3Ј cleavage products by RNA ligase (reviewed in references 6, 13, and 28).RNA editing occurs in association with a ribonucleoprotein complex which sediments at 20S in glycerol gradients (4, 22). Fractionation and hence partial purification of the complex by glycerol gradient and liquid chromatographic techniques have been reported (4,18,22,24). For the most part, these preparations were insufficient to identify specific proteins that are part of the editing complex. However, Rusché et al. (24) suggested that a complex of eight proteins could catalyze editing. They concluded that three of these proteins were adenylylatable and suggested that they represented the editing RNA ligase, although the role of these proteins has not yet been demonstrated. Indeed, little progress has been made on the definitive identification of proteins that are components of the editing complex. Three T. brucei mitochondrial proteins, gBP21 (15), DEAD box protein mHEL61p (19), and REAP1 (18...
The editosome is a multiprotein complex that catalyzes the insertion and deletion of uridylates that occurs during RNA editing in trypanosomatids. We report the identification of nine novel editosome proteins in Trypanosoma brucei. They were identified by mass spectrometric analysis of functional editosomes that were purified by serial ion exchange/gel permeation chromatography, immunoaffinity chromatography specific to the TbMP63 editosome protein, or tandem affinity purification based on a tagged RNA editing ligase. The newly identified proteins have ribonuclease and/or RNA binding motifs suggesting nuclease function for at least some of these. Five of the proteins are interrelated, as are two others, and one is related to four previously identified editosome proteins. The implications of these findings are discussed.
The fax-1 gene of the nematode C. elegans encodes a conserved nuclear receptor that is the ortholog of the human PNR gene and functions in the specification of neuron identities. Mutations in fax-1 result in locomotion defects. FAX-1 protein accumulates in the nuclei of 18 neurons, among them the AVA, AVB, and AVE interneuron pairs that coordinate body movements. The identities of AVA and AVE interneurons are defective in fax-1 mutants; neither neuron expresses the NMDA receptor subunits nmr-1 and nmr-2. Other ionotropic glutamate receptor subunits are expressed normally in the AVA and AVE neurons. The unc-42 homeobox gene also regulates AVA and AVE identity; however, unc-42 mutants display the complementary phenotype: NMDA receptor subunit expression is normal, but some non-NMDA glutamate receptor subunits are not expressed. These observations support a combinatorial role for fax-1 and unc-42 in specifying AVA and AVE identity. However, in four other neuron types, fax-1 is regulated by unc-42, and both transcriptional regulators function in the regulation of the opt-3 gene in the AVE neurons and the flp-1 and ncs-1 genes in the AVK neurons. Therefore, while fax-1 and unc-42 act in complementary parallel pathways in some cells, they function in overlapping or linear pathways in other cellular contexts, suggesting that combinatorial relationships among transcriptional regulators are complex and cannot be generalized from one neuron type to another.
Control of the regenerative properties of urothelial tissue would greatly aid the clinician in the management of urinary tract disease and disorders. Fibroblast growth factor 10 (FGF-10) is a mitogen which is particularly promising as a protein therapy for urothelial injury. The spatial synthesis, transport, targeting, and mechanistic pathway of FGF-10 and its receptor were studied in a human urothelial cell culture model and in fixed sections of lower urinary tract tissue. Synthesis of FGF-10 was restricted to mesenchymal fibroblasts, and secreted FGF-10 exhibited paracrine transport to two proximal sites, transitional epithelium and smooth muscle cell bundles, both of which were also the exclusive sites of FGF-10 receptor synthesis. The addition of recombinant FGF-10 to quiescent urothelial cells in vitro was sufficient to stimulate DNA synthesis. This stimulation was through a pathway independent of the epidermal growth factor receptor pathway. Deconvolution, light and transmission electron microscopic studies captured FGF-10 and its receptor in association with the urothelial cell surface, in cytoplasm, and within nuclei, observations that describe the mechanism that transduces the mitogenic signal in these tissues. Localization of the FGF-10 receptor to the superficial urothelial layer is clinically significant because intravesical administration of FGF-10 may provide the clinician a means to control the turnover of transitional epithelium in bladder disorders such as interstitial cystitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.